SINOTHERAPEUTICS INC.

Otros idiomas Sinotherapeutics Inc.

Acciones

688247

CNE100005PL9

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
8,65 ^CNY	-2,26 %		+6,00 %	-21,22 %

29/04	Sinotherapeutics Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
23/02	Sinotherapeutics Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.	02/04
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sinotherapeutics Inc. announces an Equity Buyback for CNY 70 million worth of its shares.	21/02
Sinotherapeutics Inc. authorizes a Buyback Plan.	19/02
Sinotherapeutics Gets Nod for Mesalazine Tablets; Shares Drop 7%	05/02
Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Sinotherapeutics' Unit Gets Registration Certificate for Sevelamer Carbonate Tablets	26/09/23
Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange A Share Index	25/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange Composite Index	25/08/23
Sinotherapeutics Gets US FDA Nod for Arthritis Drug	10/08/23
Sinotherapeutics Signs Product Licensing Deal With US Drugmaker Lannett	07/08/23
FDA Greenlights Sinotherapeutics' Mesalazine Enteric-Coated Tablets	17/05/23
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Sinotherapeutics Drug Selected in China's Centralized Drug Procurement	13/04/23
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Sinotherapeutics’ Antifungal Drug Added to China’s Medical Insurance Catalog	19/01/23
Sinotherapeutics Inc. has completed an IPO in the amount of CNY 424.8358 million.	22/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Asegure y Aumente el Rendimiento de sus Inversiones con nuestro Equipo de Expertos a su lado

Asegurar mis Inversiones

fermer